That is necessary, because the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work. Simply put, we have to know how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error procedure (the legacy report prediction). Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're designed to do. This was an advancement almost nobody saw. However it's going to have extensive implications for treating illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of investment opportunities in this space, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (united states). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it pulled back perhaps considerably prior to going greater - united arab emirates. I've been covering bitcoin for a long period of time now. Among the first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were mostly educating readers. But that's not the huge question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. jeff brown 1 biotech company. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are so numerous terrific personal business on the edge of hitting the general public markets And I've been working on a new way for you to invest even before these business go public.
This chance has actually been building over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to book your area free of charge.
Emma Walsh here, handling editor of the Journal. Regular Journal readers understand that tech isn't our normal beat (jeff brown prediction). And when it comes to tech investing, we leave it to the experts. The good news is, we have several such specialists in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing experts we understand (jeff brown prediction). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and predict what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and a lot more. These trends are experiencing rapid growth and producing incredible chances for investors. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown predictions for 2021. However regardless of what many readers might believe, this is a trend that's simply getting going. Even though the COVID-19 pandemic disrupted supply chains last year, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown 2020 predictions). Losing two months of production and sales really impacts the number of 5G devices are sold in the fiscal year. When you consider all of that, offering 250 million systems is exceptional. More significantly, the delays triggered by the pandemic created a lots of suppressed need. And that need is now going to be pushed into 2021. In reality, I forecast that more than 500 million 5G devices will be shipped in 2021 - jeff brown stock picks 2021. Which's not my only 5G prediction When I have actually spoken about 5G in the past, I've described its 3 various phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Stage Three, 5G services begin to be used (jeff brown stock market prediction). That's when we start to see applications working on 5G networks. Think of things like massive multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase 3 by this summer. This starts something of a virtuous cycle: The majority of individuals do not really care about the technology. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open up a suite of incredible applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these innovations require 5G. The investment chances moving forward will be enormous. Stepping far from 5G, the next important innovation I predict in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it is among the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software application.
The program can crash or not function properly. CRISPR uses a similar concept but with our hereditary code. "Typos" in our genome can cause disease. CRISPR can fix these "typos." For several years, CRISPR was primarily a niche innovation that wasn't well understood. And throughout that time, there were actually just 3 business running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and delivering amazing returns. This whole industry is efficiently a greenfield chance.
There's space for numerous companies to exist in this area. bleeding edge. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or 3 more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things happening at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software can accurately forecast the folding of a protein based exclusively on its amino acid series with 92. 4% accuracy. That is essential because the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and be efficient.
Historically, this has actually been an experimental process. However now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but numerous drug treatments produced utilizing this innovation. This was among those breakthroughs that nearly nobody saw. But it's going to have profound ramifications for curing illness. And, obviously, there will be lots of financial investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it drew back maybe significantly prior to going higher. I have actually been covering bitcoin for a long period of time now. One of the first research study reports I ever released was on bitcoin - last year. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. But at the time of that initial recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that question any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. angel investor. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the information depends on date as of February 2021, however we could not independently confirm this claim. Offered Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like capability to choose winning technology stocks. He invested more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an excellent perspective on the market. He's constantly on the hunt for new chances, and he shares numerous of his finest picks in the Near Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an outstanding credibility as a stock-picker, and he effectively forecasted a few of the greatest financial occasions of the past twenty years. Although he does not appear to release his picks to the general public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it right whenever, but Jeff Brown's precise forecasts have earned him legions of dedicated fans. That says a lot about his capability. The Near Future Report is released by Brownstone Research study, a popular monetary research study publisher. Brownstone Research study provides a number of research study services with a broad range of expertises - self-driving cars.
The company is likewise affiliated with Bonner & Partners, another well-respected research study publisher - jeff brown 2021 predictions. On its site, Brownstone states its objective is to offer retail investors with professional-grade research: "For too long, the very best investment research study has actually not been offered to private financiers. It has actually been typically scheduled for investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown prediction for 2021. The mission of Brownstone Research is to make that kind of exclusive research readily available to any investors seeking to acquire an edge in the marketplaces. The goal is easy to deliver unique and lucrative investment research study discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also serves as the company's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to offer its customers. After years of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout the majority of America. If you understand even a little bit about the marketplace, you know that he has a track record as a King Midas of sorts. jeff brown biotech picks. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown thinks S.A.V. exponential growth. might be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying two cutting-edge innovations: expert system and electric automobiles. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving cars and trucks ever. It's nothing except the vehicle market's Holy Grail. As you know, electrical cars and self-driving vehicle stocks have actually been huge this year, however the Wall Street machine has approved hype without much concrete result. Despite a drastic increase in competition over the previous couple of years, Brown still thinks Musk has the very best possibility of putting all of it together.
tech might be the magic string that ties everything together. S.A.V. represents Shared Autonomous Lorry, and it might be the future of transportation. Essentially, this innovation would allow you to rent your vehicle as a self-governing, self-driving taxi when you're not using it. You simply get out of the automobile and press a button on an app that tells the automobile to "sign up with the fleet." Next thing you understand, you're unwinding on your sofa while your automobile shuttles ride-sharers around town. Best of all, you get to keep a hefty piece of the revenues. It sounds crazy, however it might be closed than you believe.